Tirzepatide research guide — dual GIP/GLP-1 receptor mechanism, study context, reconstitution and handling. For laboratory research use only.
Tirzepatide is a novel synthetic peptide that acts as a dual agonist of both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. With a molecular weight of approximately 4813.52 g/mol and CAS number 2023788-19-2, it represents a significant advancement in incretin-based research. Unlike single-receptor agonists, tirzepatide's dual mechanism of action allows researchers to study the combined effects of GLP-1 and GIP receptor activation.
Tirzepatide activates both GLP-1 and GIP receptors, two key incretin hormones involved in glucose homeostasis and metabolic regulation. GLP-1 receptor activation is associated with insulin secretion, glucagon suppression, and gastric emptying regulation. GIP receptor activation plays roles in insulin release, lipid metabolism, and adipose tissue function. The dual-agonist approach provides a unique tool for studying the synergistic effects of both pathways simultaneously.
Metabolic pathway studies: investigating the combined effects of GLP-1 and GIP receptor activation on glucose metabolism. Incretin research: studying the interaction between the two incretin pathways. Receptor binding studies: comparative analysis of dual vs single receptor agonism. Cellular signalling: examining downstream signalling cascades from dual receptor activation. Comparative studies: comparing dual agonism to single GLP-1 agonists such as semaglutide.
While traditional GLP-1 receptor agonists (such as semaglutide and liraglutide) target only the GLP-1 receptor, tirzepatide additionally activates GIP receptors. Retatrutide goes further as a triple agonist, also targeting glucagon receptors. This spectrum of receptor selectivity provides researchers with tools to study each pathway individually and in combination, contributing to the understanding of incretin biology.
Molecular Weight: 4813.52 g/mol. CAS Number: 2023788-19-2. Purity: ≥99.5% (HPLC verified). Form: Lyophilised white powder. Solubility: Soluble in bacteriostatic water. Storage: -20°C (lyophilised), 2-8°C (reconstituted).
Research-grade compounds referenced in this guide, supplied with full Certificates of Analysis.
All products sold by Neovia Peptides are strictly for in-vitro research and laboratory use only. Not intended for human or veterinary use, food additives, drugs, or cosmetics. By purchasing from this website, you agree that you understand and accept these terms.
